Consequently, we comprehensively examined characteristics such as gene expression, proteomic expression, DNA methylation, survival analysis, genetic alteration, immune infiltration, and pathway analysis to characterize CCT5 in 33 TCGA tumor types. The gene discussed is CCT5; the disease is neoplasm.